Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JKB-122 in Patients With NASH and Fibrosis
NCT04255069Phase 2Unknown
- Sponsor
- TaiwanJ Pharmaceuticals Co., Ltd.
- Start
- Jun 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of naltrexone in Nonalcoholic steatohepatitis (NASH), sponsored by TaiwanJ Pharmaceuticals Co., Ltd.. Status: unknown.
02
Drugs
naltrexone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04255069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04255069.